AVNS
AVANOS MEDICAL, INC.
Next earnings Aug 3, 2026 · consensus $0.17 EPS, $176M rev
Last earnings +0.2% on 2026-05-05
$24.95
▲ +0.20%$24.95▲ +105.52%
over 1Y
L $9.89EODHDH $25.05
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.2%
1W+0.2%
1M+0.6%
3M+84.5%
YTD+123.2%
1Y+105.5%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 6 analysts
Sell
Conservative balance sheet (liabilities/equity 0.38x); but unprofitable (net margin -10.4%).
AVANOS MEDICAL, INC. shows $701M in FY2025 revenue (+1.9% YoY), a -10.4% net margin, and -9.4% ROE.
Sources: SEC EDGAR (CIK 0001606498, latest 10-Q filed 2026-05-05) · EODHD · as of 6/26/2026, 6:47:48 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.